ISSN (Online): 2035-648X
Fast search with keyword
It provides easy access to our database
  
 

 
   
 
Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series
 

Type:  Articles

Pubblication date:  07/2018

Authors:  J.A. Garrocho-Rangel*, M. Herrera-Moncada*, R. Márquez-Preciado*, F. Tejeda-Nava*, J. J. Ortiz-Zamudio**, A. Pozos-Guillén*

Language:  English

Institution:  *Pediatric Dentistry Postgraduate Program, Faculty of Dentistry, San Luis Potosi University, San Luis Potosí, SLP, México. ** Pediatric Oncology Specialist. Department of Oncology. Hospital Central “Ignacio Morones Prieto”. San Luis Potosí, México

Publication:  European Journal of Paediatic Dentistry

Publisher:  Ariesdue Srl

Keywords:  Acute lymphoblastic leukemia, Chemotherapy, Children, Methotrexate.

Email:  apozos@uaslp.mx


Title:  Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series

Abstract:  Aim Oral mucositis (OM) is a painful and inflammatory ulcerative lesion occurring as an adverse effect during chemotherapy in children with acute lymphoblastic leukemia (ALL). This condition may cause significant systemic anomalies such as malnutrition, opportunistic infections, and delay in the chemotherapy course. This report aims to describe a case series of 11 ALL patients treated with methotrexate as chemotherapy agent. Case series Each patient was carefully followed-up and orally examined for 14 days after their chemotherapy session. OM occurred in all children. Then, the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO) management protocol for OM was applied to them. The mean time of the lesion total resolution was 3.7 days. Conclusions It is necessary to emphasise the importance of early detection of OM through a close clinical oral examination of children and adolescents with ALL undergoing methotrexate chemotherapy. Pain/infection control and the maintenance of good levels of oral hygiene are fundamental during the management of OM. Therefore, paediatric dentists need to be part of the oncology care team, and thus contributing and helping with ALL treatment.

 
 
 
 
 
Home   |   Editorial Board   |   Referees   |   Current issue   |   Article submission   |   Links   |   Contact us

Editor in chief: dott. Luigi Paglia ejpd.editor@gmail.com
European Journal of Paediatric Dentistry © | ISSN (Online): 2035-648X |
Privacy Policy | Term of use